References
- Belpomme D, Gauthier S, Pujade-Lauraine E, et al (2000). Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma. Ann Oncol, 11, 1471-6. https://doi.org/10.1023/A:1026556119020
- Bergman GJ, Khan S, Danielsson B, et al.(2014). Breast cancer risk and use of calcium channel blockers using Swedish population registries. JAMA Intern Med, 174, 1700-1. https://doi.org/10.1001/jamainternmed.2014.3867
- Chae YK, Dimou A, Pierce S, et al(2014). The effect of calcium channel blockers on the outcome of acute myeloid leukemia. Leuk Lymphoma, 55, 2822-9. https://doi.org/10.3109/10428194.2014.901513
- Choi DL, Jang SJ, Cho S, et al (2014). Inhibition of cellular proliferation and induction of apoptosis in human lung adenocarcinoma A549 cells by T-type calcium channel antagonist. Bioorg Med Chem Lett, 24, 1565-70. https://doi.org/10.1016/j.bmcl.2014.01.071
- Chong VH, Telisinghe PU, Lim E, et al (2016). Cancers among south-east asian nationals in brunei darussalam. Asian Pac J Cancer Prev, 17, 845-9. https://doi.org/10.7314/APJCP.2016.17.2.845
- Coleman CI, Baker WL, Kluger J, et al (2008). Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens, 26, 622-9. https://doi.org/10.1097/HJH.0b013e3282f3ef5e
- Fan Y, Zhou Y, Gong D, et al (2015). No evidence for increased prostate cancer risk among calcium channel blockers user. Int J Cardiol, 201, 255-7. https://doi.org/10.1016/j.ijcard.2015.08.046
- Grimaldi-Bensouda L, Klungel O, Kurz X, et al (2016). Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD). BMJ Open, 6, 9147.
- Guo DQ, Zhang H, Tan SJ, et al (2014). Nifedipine promotes the proliferation and migration of breast cancer cells. PLoS One, 9, 113649. https://doi.org/10.1371/journal.pone.0113649
- Hashim D, Boffetta P, La Vecchia C, et al (2016). The global decrease in cancer mortality: trends and disparities. Ann Oncol, 27, 926-33 https://doi.org/10.1093/annonc/mdw027
- He LR, Qiao W, Liao ZX, et al (2015). Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma. BMC Cancer, 15, 111. https://doi.org/10.1186/s12885-015-1095-2
- Holmes S, Griffith EJ, Musto G, et al (2013). Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study. Cancer Epidemiol, 37, 881-5. https://doi.org/10.1016/j.canep.2013.09.001
- Kaddour-Djebbar I, Choudhary V, Lakshmikanthan V, et al (2012). Diltiazem enhances the apoptotic effects of proteasome inhibitors to induce prostate cancer cell death. J Pharmacol Exp Ther, 341, 646-55. https://doi.org/10.1124/jpet.111.188151
- Koski A, Raki M, Nokisalmi P, et al (2012). Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer. Mol Ther, 20, 221-9. https://doi.org/10.1038/mt.2011.230
- Lebuffe G, Dosseh ED, Tek G, et al (2005). The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia, 60, 439-44. https://doi.org/10.1111/j.1365-2044.2005.04156.x
- Lindberg G, Lindblad U, Low-Larsen B, et al (2002). Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study. Pharmacoepidemiol Drug Saf, 11, 493-7. https://doi.org/10.1002/pds.737
- Millward MJ, Cantwell BM, Munro NC, et al (1993). Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study. Br J Cancer, 67, 1031-5. https://doi.org/10.1038/bjc.1993.189
- Moore M, Manan A, Chow K, et al (2008). Cancer epidemiology and control in peninsular and island south-east asia - past, present and future. Asian Pac J Cancer Prev, 9, 81-98.
- Mross K, Bohn C, Edler L, et al (1993). Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. Ann Oncol, 4, 45-50. https://doi.org/10.1093/oxfordjournals.annonc.a058356
- Nakai Y, Isayama H, Sasaki T, et al (2013). Clinical outcomes of chemotherapy for diabetic and nondiabetic patients with pancreatic cancer: better prognosis with statin use in diabetic patients. Pancreas, 42, 202-8. https://doi.org/10.1097/MPA.0b013e31825de678
- Ning Z, Chen D, Liu A, et al (2014). Efficacy of chemotherapy combined with targeted arterial infusion of verapamil in patients with advanced gastric cancer. Cell Biochem Biophys, 68, 195-200. https://doi.org/10.1007/s12013-013-9689-2
- Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints. Stat Med, 17, 2815-34. https://doi.org/10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
- Poch MA, Mehedint D, Green DJ, et al (2013). The association between calcium channel blocker use and prostate cancer outcome. Prostate, 73, 865-72. https://doi.org/10.1002/pros.22632
- Salim E, Moore M, Al-Lawati J, et al (2009). Cancer epidemiology and control in the arab world - past, present and future. Asian Pac J Cancer Prev, 10, 3-10.
- Saltzman BS, Weiss NS, Sieh W, et al (2013). Use of antihypertensive medications and breast cancer risk. Cancer Causes Control, 24, 365-71. https://doi.org/10.1007/s10552-012-0122-8
- Sarfati D, Koczwara B, Jackson C (2016). The impact of comorbidity on cancer and its treatment. CA Cancer J Clin, 66, 337-50. https://doi.org/10.3322/caac.21342
- Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25, 603-5. https://doi.org/10.1007/s10654-010-9491-z
- Tierney JF, Stewart LA, Ghersi D, et al (2007). Practical methods for incorporating summary time-to-event data into metaanalysis. Trials, 8, 1-16. https://doi.org/10.1186/1745-6215-8-1
- Vardar-Yagli N, Sener G, Saglam M, et al (2015). Associations among Physical Activity, Comorbidity, Functional Capacity, Peripheral Muscle Strength and Depression in Breast Cancer Survivors. Asian Pac J Cancer Prev, 16, 585-9. https://doi.org/10.7314/APJCP.2015.16.2.585
- Williams GR, Mackenzie A, Magnuson A, et al (2015). Comorbidity in older adults with cancer. J Geriatr Oncol, 26725537.
- Wirasorn K, Suwanrungruag K, Wiangnon S, et al (2014). Numbers of new cases and trends of cancer 1993-2012: srinagarind hospital based population, Khon Kaen, North- East Thailand. Asian Pac J Cancer Prev, 15, 8423-7. https://doi.org/10.7314/APJCP.2014.15.19.8423
- Wong MC, Tam WW, Lao XQ, et al (2015). The incidence of cancer deaths among hypertensive patients in a large Chinese population: a cohort study. Int J Cardiol, 179, 178-85. https://doi.org/10.1016/j.ijcard.2014.10.028
- Woodward M (2014). A Consensus Plan for Action to Improve Access to Cancer Care in the Association of Southeast Asian Nations (ASEAN) Region. Asian Pac J Cancer Prev, 15, 8521-6. https://doi.org/10.7314/APJCP.2014.15.19.8521
- Xuan Z, Zhong Z, Zhang X, et al (2012). Comorbidity Relationship to Outcome of Radical Cystectomy in Chinese: a Single Institution Study with the ACE-27 Comorbidity Index. Asian Pac J Cancer Prev, 13, 827-31. https://doi.org/10.7314/APJCP.2012.13.3.827